Gain of Nrf2 Function in Non-Small-Cell Lung Cancer Cells Confers Radioresistance
- 1 December 2010
- journal article
- research article
- Published by Mary Ann Liebert Inc in Antioxidants and Redox Signaling
- Vol. 13 (11), 1627-1637
- https://doi.org/10.1089/ars.2010.3219
Abstract
Nuclear factor erythroid-2 related factor 2 (Nrf2), a redox-sensitive transcription factor, regulates the expression of antioxidant enzymes and several anti-apoptotic proteins, which confer cytoprotection against oxidative stress and apoptosis. Constitutive activation of Nrf2 in lung cancer cells promotes tumorigenicity and contributes to chemoresistance by upregulation of glutathione, thioredoxin, and the drug efflux pathways involved in detoxification of electrophiles and broad spectrum of drugs. In this study, we show that RNAi-mediated lowering of Nrf2 levels in non-small-cell lung cancer (NSCLC) cell lines (A549 and H460) led to a dramatic increase in endogenous reactive oxygen species (ROS) levels. Similarly, γ-irradiation-induced formation of protein carbonyls were significantly higher in Nrf2-depleted lung cancer cells, suggesting increased lethality of ionizing radiation in the absence of Nrf2. Radiation-induced protein oxidation in Nrf2shRNA cells correlated with reduced survival as measured by clonogenic assay. Radiation-induced cell death was abrogated by pretreatment with antioxidants such as N-acetyl-L-cysteine, glutathione, and vitamin-E, highlighting the importance of antioxidants in conferring protection against radiation injury. Using genetically-modified gain and loss of function models of Nrf2, in mouse embryonic fibroblasts, we establish that constitutive activation of Nrf2 protects against ionizing radiation toxicity and confers radioresistance. Thus, targeting Nrf2 activity in radioresistant tumors could be a promising strategy to circumvent radioresistance. Antioxid. Redox Signal. 13, 1627–1637.Keywords
This publication has 46 references indexed in Scilit:
- Association of reactive oxygen species levels and radioresistance in cancer stem cellsNature, 2009
- RNAi-Mediated Silencing of Nuclear Factor Erythroid-2–Related Factor 2 Gene Expression in Non–Small Cell Lung Cancer Inhibits Tumor Growth and Increases Efficacy of ChemotherapyCancer Research, 2008
- Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancyProceedings of the National Academy of Sciences of the United States of America, 2008
- A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activityBiochemical and Biophysical Research Communications, 2007
- NRF2 Modulates Aryl Hydrocarbon Receptor Signaling: Influence on AdipogenesisMolecular and Cellular Biology, 2007
- Deficiency in Nrf2-GSH Signaling Impairs Type II Cell Growth and Enhances Sensitivity to OxidantsAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- Glutathione Peroxidase 2, the Major Cigarette Smoke–Inducible Isoform of GPX in Lungs, Is Regulated by Nrf2American Journal of Respiratory Cell and Molecular Biology, 2006
- Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-ImidazolideBiochemical and Biophysical Research Communications, 2006
- The Consensus Coding Sequences of Human Breast and Colorectal CancersScience, 2006
- Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung CancerPLoS Medicine, 2006